ACTRN12608000087358招募中2 期
Effects of tetrahydrobiopterin (BH4) on myocardial blood flow and vascular function in coronary artery disease.
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Treatment
- 盲法
- Blinded (masking used)
入排标准
- 年龄范围
- 50 Years 至 80 Years（—）
- 性别
- All
入选标准
- •stable angina
排除标准
- •renal failure, unsuitable for Magnetic Resonance Imaging
研究者
相似试验
进行中（未招募）
不适用
Effects of tetrahydrobiopterin (6R-BH4) on flow-mediated dilation in CADASIL patients: a randomised controlled trial - CADASIL BH4EUCTR2007-004370-55-ITAZIENDA OSPEDALIERA OSPEDALE NIGUARDA CA' GRANDA (A.O. DI RILIEVO NAZIONALE)
撤回
4 期
Effects of Tetrahydrobiopterin (BH4) on Leg Blood Flow and Exercise Capacity in Patients With Peripheral Artery DiseasePeripheral Artery DiseasePeripheral Arterial DiseaseNCT03493412University of Nebraska
已完成
早期 1 期
Effects of Tetrahydrobiopterin on Blood PressureHypertensionNCT00208780Emory University24
进行中（未招募）
1 期
BH4 (Kuvan©) treatment in Phenylketonuria - comparing different practices of dosing regimensOMIM 261600)Phenylketonuria (PKUEUCTR2021-003777-63-NLniversity Medical Center Groningen28
已完成
2 期
Study of BH4, a New and Simple Treatment of Mild PKUPhenylketonuriaNCT00260000The Kennedy Institute-National Eye Clinic15